These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31272707)

  • 1. Consensus of the Iberoamerican Oculoplastic Society for diagnosis and management of facial dystonia.
    Núñez Medrano JA; Fernández E; Georgescu D; Díaz Díaz AL; Graue Moreno G
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Sep; 94(9):436-440. PubMed ID: 31272707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm.
    Karp BI; Alter K
    Semin Neurol; 2016 Feb; 36(1):84-91. PubMed ID: 26866500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Botulinum toxin therapy for focal dystonia].
    Hahn K; Niklai E; Garzuly F; Szupera Z
    Orv Hetil; 2009 Jul; 150(29):1381-4. PubMed ID: 19581172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Kenney C; Jankovic J
    J Neural Transm (Vienna); 2008; 115(4):585-91. PubMed ID: 17558461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm.
    Chang LB; Tsai CP; Liao KK; Kao KP; Yuan CL; Yen DJ; Lin KP
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jan; 62(1):1-5. PubMed ID: 10063705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome.
    Czyz CN; Burns JA; Petrie TP; Watkins JR; Cahill KV; Foster JA
    Am J Ophthalmol; 2013 Jul; 156(1):173-177.e2. PubMed ID: 23541393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facial muscle spasms: an Australian study.
    Kowal L; Davies R; Kiely PM
    Aust N Z J Ophthalmol; 1998 May; 26(2):123-8. PubMed ID: 9630292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemifacial spasm].
    Krystkowiak P
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S142-5. PubMed ID: 19576481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.
    Kraft SP; Lang AE
    CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.
    Bastola P; Chaudhary M; Agrawal JP; Shah DN
    Kathmandu Univ Med J (KUMJ); 2010; 8(31):305-10. PubMed ID: 22610735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel task-specific dystonia type: Hemifacial spasm in a photographer.
    Kargiotis O; Geka A; Tsivgoulis A; Veltsista D; Xiromerisiou G; Tsivgoulis G
    Neurol Sci; 2021 Mar; 42(3):1151-1152. PubMed ID: 33156408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical symptoms, diagnosis and treatment of focal dystonias].
    Klivényi P; Vécsei L
    Orv Hetil; 2001 Oct; 142(42):2293-7. PubMed ID: 11760645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Botulinum toxin in the treatment of facial dystonia: evaluation of its efficacy and patients' satisfaction along the treatment].
    Costa PG; Aoki L; Saraiva FP; Matayoshi S
    Arq Bras Oftalmol; 2005; 68(4):471-4. PubMed ID: 16322831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blepharospasm and Hemifacial Spasm.
    Yen MT
    Int Ophthalmol Clin; 2018; 58(1):1. PubMed ID: 29239872
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lacrimal film evaluation of patients with facial dystonia during botulinum toxin type A treatment].
    Costa PG; Cardoso IP; Saraiva FP; Raiza AC; Tanaka LK; Matayoshi S
    Arq Bras Oftalmol; 2006; 69(3):319-22. PubMed ID: 16936952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Craniocervical dystonia: clinical and pathophysiological features.
    Colosimo C; Suppa A; Fabbrini G; Bologna M; Berardelli A
    Eur J Neurol; 2010 Jul; 17 Suppl 1():15-21. PubMed ID: 20590803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins.
    Hassell TJW; Charles D
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32331272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Facial tics and spasms].
    Potgieser AR; van Dijk JM; Elting JW; de Koning-Tijssen MA
    Ned Tijdschr Geneeskd; 2014; 158():A7615. PubMed ID: 24988167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term therapy of focal dystonia and facial hemispasm with botulinum toxin A].
    Vogt T; Lüssi F; Paul A; Urban P
    Nervenarzt; 2008 Aug; 79(8):912-7. PubMed ID: 18551268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facial dystonia, essential blepharospasm and hemifacial spasm.
    Holds JB; White GL; Thiese SM; Anderson RL
    Am Fam Physician; 1991 Jun; 43(6):2113-20. PubMed ID: 2042553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.